Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Calcium Hydroxide Versus Triple Antibiotic Paste for Pain After Root Canal Treatment

2 november 2026 uppdaterad av: Muzdalfa hanif, Rehman Medical Institute - RMI

Comparative Evaluation of Calcium Hydroxide and Triple Antibiotic Paste on Postoperative Pain in Teeth With Symptomatic Apical Periodontitis: A Randomized Clinical Trial

The goal of this clinical trial is to learn whether triple antibiotic paste reduces pain after root canal treatment more than calcium hydroxide in adults aged 18 to 70 years who have a dead (necrotic) tooth with painful infection at the root tip (symptomatic apical periodontitis). The main question it aims to answer is:

Does placing triple antibiotic paste inside the root canal lower pain 72 hours after treatment compared with calcium hydroxide?

Researchers will compare triple antibiotic paste (a mix of three antibiotics: ciprofloxacin, metronidazole and minocycline) with calcium hydroxide, the medicine most commonly placed inside root canals between dental visits, to see which one leads to less pain after treatment.

Participants will Receive root canal cleaning and shaping of the affected tooth Have either calcium hydroxide or triple antibiotic paste placed inside the root canal, decided by chance Rate their pain on a 0 to 10 scale 72 hours after treatment

Studieöversikt

Detaljerad beskrivning

Pain after root canal treatment is common in teeth with symptomatic apical periodontitis and is linked to bacteria and their by-products remaining in the complex root canal system. Calcium hydroxide is widely used as an inter-appointment intracanal medicament because of its high alkalinity and antibacterial action, but some bacteria commonly found in infected root canals are resistant to it. Triple antibiotic paste combines ciprofloxacin, metronidazole and minocycline. Together they act against Gram-positive, Gram-negative and anaerobic bacteria, which may reduce the remaining bacterial load and periapical inflammation more effectively.

This is a two-arm, parallel-group randomized clinical trial conducted at the Department of Operative Dentistry and Endodontics, Rehman Medical Institute, Peshawar, Pakistan. Patients are recruited consecutively. Written informed consent is obtained from each patient or guardian. Baseline age, sex, tooth treated and preoperative pain are recorded on a standardized proforma.

Participants are allocated in a 1:1 ratio to the calcium hydroxide group (Group A) or the triple antibiotic paste group (Group B) by permuted block randomization with a block size of 4. The sequence is computer-generated. Allocation is concealed in sequentially numbered, opaque, sealed envelopes opened only after the patient's enrolment.

All teeth receive the same treatment under local anaesthesia and rubber dam isolation. The working length is set with an electronic apex locator and confirmed radiographically. Canals are cleaned and shaped with a rotary nickel-titanium system (ProTaper Gold, Dentsply Sirona) and irrigated with 2.5% sodium hypochlorite. The smear layer is removed with 17% EDTA for 1 minute, followed by a final saline rinse, to improve penetration of the medicament into dentinal tubules. Canals are dried with paper points.

Group A receives calcium hydroxide paste (Metapex or equivalent commercial preparation). Group B receives triple antibiotic paste made from ciprofloxacin, metronidazole and minocycline in a 1:1:1 ratio, mixed with propylene glycol to a creamy consistency. The medicament is placed with a lentulo spiral to working length, and the access cavity is sealed with a sterile cotton pellet and a temporary restoration (Cavit, 3M ESPE). The medicament stays in place for 7 days until the next appointment.

Pain is recorded by the patient on a 0 to 10 Visual Analog Scale at 72 hours after treatment and grouped as no pain (0), mild (1 to 3), moderate (4 to 6) or severe (7 to 10). The sample size of 138 patients (69 per group) was calculated with reference to Narayanan et al. (2022). Data are analysed in SPSS. Mean pain scores are compared between groups with the independent-samples t-test, and pain categories with the chi-square test. Pain category is also stratified by age and gender. A p-value below 0.05 is considered significant.

Your manuscript lists these as two separate steps: EDTA rinse and then medicament placement. Paste the next set of form questions when you reach them.

Studietyp

Interventionell

Inskrivning (Faktisk)

138

Fas

  • Fas 4

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

      • Peshawar, Pakistan
        • Rehman Medical Institute

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 70 år (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Patients aged 18 to 70 years
  • Both males and females
  • Teeth with pulp necrosis and a clinical diagnosis of symptomatic apical periodontitis
  • Teeth with a closed apex and fully developed roots
  • Willing to give written informed consent

Exclusion Criteria:

  • Use of antibiotics or analgesics in the 24 hours before treatment
  • Previous root canal treatment on the involved tooth
  • Teeth with anatomical anomalies, root resorption or incomplete root formation
  • Pregnant or breastfeeding women

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Dubbel

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Aktiv komparator: Calcium Hydroxide

Participants received calcium hydroxide paste as the intracanal medicament after cleaning, shaping and EDTA smear-layer removal. The paste was left in the canal for 7 days.

Calcium hydroxide paste placed in the root canal with a lentulo spiral to working length as an inter-appointment intracanal medicament.

Experimentell: Triple Antibiotic Paste

Participants received triple antibiotic paste (ciprofloxacin, metronidazole and minocycline, 1:1:1, mixed with propylene glycol) as the intracanal medicament after cleaning, shaping and EDTA smear-layer removal. The paste was left in the canal for 7 days.

Equal parts ciprofloxacin, metronidazole and minocycline mixed with propylene glycol, placed in the root canal with a lentulo spiral to working length as an inter-appointment intracanal medicament.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Postoperative Pain Intensity
Tidsram: 72 hours after treatment

Pain intensity was self-reported by participants on a 0 to 10 Visual Analog Scale, where 0 = no pain and 10 = worst imaginable pain. Higher scores indicate worse pain. Mean scores were compared between the calcium hydroxide and triple antibiotic paste groups.

72 hours after treatment

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Postoperative Pain Severity Category
Tidsram: 72 hours after treatment

Number of participants in each pain category, based on the 0 to 10 Visual Analog Scale score: no pain (0), mild (1 to 3), moderate (4 to 6) and severe (7 to 10). Proportions were compared between groups.

72 hours after treatment

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

1 februari 2026

Primärt slutförande (Faktisk)

14 augusti 2026

Avslutad studie (Faktisk)

26 augusti 2026

Studieregistreringsdatum

Först inskickad

2 november 2026

Först inskickad som uppfyllde QC-kriterierna

2 november 2026

Första postat (Faktisk)

6 november 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

6 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

2 november 2026

Senast verifierad

1 november 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera